Cocrystal Pharma, Inc.
COCP
Revenue
510.00k
▲21.00k▲4.29%
3 Months ChangeAssets
21.57M
▼-4.97M▼-18.73%
3 Months ChangeLiabilities
4.18M
▲222.00k▲5.60%
3 Months ChangeFree Cash Flow
-4.51M
▼-1.36M▼-42.93%
12 Months ChangeRevenue/Cost Of Revenue
Revenue
Cost Of Revenue
Loading...
| Date | Revenue | Cost Of Revenue |
|---|---|---|
Net Profit/Loss
Net Profit/Loss
Baseline
Loading...
| Date | Net Profit/Loss |
|---|---|
Assets/Liabilities
Assets
Liabilities
Loading...
| Date | Assets | Liabilities |
|---|---|---|
Cash Flows
Operating (Cash Flow)
Investing (Cash Flow)
Financing (Cash Flow)
Free Cash Flow
Loading...
| Date | Operating (Cash Flow) | Investing (Cash Flow) | Financing (Cash Flow) | Free Cash Flow |
|---|---|---|---|---|
EPS
EPS (Diluted)
Loading...
| Date | EPS | EPS (Diluted) |
|---|---|---|
Outstanding Shares
Loading...
| Date | Outstanding Shares |
|---|---|
Recent 8-K/10-Q Filings
2024-10-31
Form 8-K
ID: 0001493152-24-043141
2024-10-10
Form 8-K
ID: 0001493152-24-040757
2024-08-20
Form 8-K
ID: 0001493152-24-033220
2024-08-14
Form 8-K
ID: 0001493152-24-031886
2024-08-14
Form 10-Q
ID: 0001493152-24-031877
2024-07-18
Form 8-K
ID: 0001493152-24-028283
2024-06-28
Form 8-K
ID: 0001493152-24-025598
2024-06-20
Form 8-K
ID: 0001493152-24-024430
2024-05-13
Form 8-K
ID: 0001493152-24-018798
2024-05-13
Form 10-Q
ID: 0001493152-24-018787